Document is current

Any future updates will be listed below

435 ES038, a novel NKCE molecule targeting LILRB4 in AML via dual engagement of NKG2A and NKG2C

Crossref DOI link: https://doi.org/10.1136/jitc-2025-SITC2025.0435

Published Online: 2025-11-04

Published Print: 2025-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark